Subscribe To
NPCE / NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
NPCE News
By GlobeNewsWire
October 16, 2023
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transfor more_horizontal
By Seeking Alpha
September 5, 2023
NeuroPace: A Speculative Epilepsy Play
NeuroPace aims to improve the lives of epilepsy patients with its remote monitoring system. The company's RNS system offers personalized and real-time more_horizontal
By Seeking Alpha
August 11, 2023
NeuroPace, Inc. (NPCE) Q2 2023 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Irina Ridley - Chief Legal Officer and more_horizontal
By Seeking Alpha
May 7, 2023
NeuroPace, Inc. (NPCE) CEO Michael Favet on Q1 2023 Results - Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Fave more_horizontal
By GlobeNewsWire
April 3, 2023
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
MOUNTAIN VIEW, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transfo more_horizontal
By Seeking Alpha
March 2, 2023
NeuroPace, Inc. (NPCE) Q4 2022 Earnings Call Transcript
NeuroPace, Inc. (NASDAQ:NPCE ) Q4 2022 Results Conference Call March 2, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Fav more_horizontal
By GlobeNewsWire
December 21, 2022
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transfor more_horizontal
By 24/7 Wall Street
November 23, 2022
Accelmed Partners Takes Activist Position in NPCE / Neuropace After Q3 Results
Fintel reports that Accelmed Partners II L.P. more_horizontal